Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by nemo3on Apr 02, 2019 3:42pm

80 Views

Post# 29572063

RE:RE:RE:With a 66% Complete Response Ph2 patients

I also hope that Ph2 yields the same results. I always like to keep a dose of my kind of reality :) in my mind and think that I have seen before where Ph 1 was great and even Ph 2 but then Ph 3 wasn't. But I think the results are remarkable and I sincerely hope for all those with cancer that they will one day be treated with success and low or no toxicity and if they can't be cured that they can be a chronic treatable case.

Bullboard Posts

Visionstate set to leverage success in the U.S. market